Replimune Group (REPL) PT Lowered to $44 at Piper Sandler
Tweet
Share
E-mailGet Alerts REPL Hot Sheet
Price: $14.21 -4.05%
Rating Summary:
10 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
10 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Piper Sandler analyst Do Kim lowered the price target on Replimune Group (NASDAQ: REPL) to $44.00 (from $52.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Shanghai Conant Optical (2276:HK) PT Lowered to HK$81.40 at Macquarie
- Edgewise Therapeutics (EWTX) PT Raised to $60 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
